The pharma industry is a mainstay of the Swiss economy and a global heavyweight. But the rise of new players could shake things up.
The two Roche towers in Basel.
Keystone / Gaetan Bally
The pharmaceutical industry is a major driver of growth and employment in Switzerland. However, pressure from the US and the rise of new players could shuffle the deck and challenge its position on the international stage. These figures and charts illustrate the significance of this flagship Swiss industry.
This content was published on
June 17, 2026 - 09:00
Pharma manufacturing in Switzerland appears to be unperturbed by the threat of tariffs but it might take several years before the…
(Bloomberg) -- At its headquarters in Basel, Swiss drugmaker Roche Holding AG employs workers from more than 100 countries. In…
Currency effects weighed on the Swiss drugmaker's first-quarter earnings
Swiss technology industry reports sharp rebound in new orders and growth in both sales and exports.
Swiss industrial production drops 6.1% in Q1 2026, with pharma and vehicles hit hard.
Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive…
